Skip to main content
Clinical Trials/ISRCTN92431452
ISRCTN92431452Completed未知

The efficacy of three weeks’ daily supplementation with two-combined probiotic strains on infant colic

Angel Children’s Hospital0 sites112 target enrollmentStarted: December 10, 2019Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
112

Study Overview

Brief Summary

2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34568236/ (added 28/09/2021)

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Crying or fussing episodes lasting more than 3 hours per day and occurring at least 3 days per week within 7 days prior to enrollment (ROME IV criteria)
  • 2. Less than 3 months (12 weeks) of age
  • 3. Equal to or greater than 37 weeks of gestation at birth
  • 4. Vaginal delivery
  • 5. Birth weight of more than 2500g
  • 6. Provided voluntary written informed consent from parents of the infant

Exclusion Criteria

  • 1. Average weight gain < 100 grams/week from birth to the last recorded weight
  • 2. Major medical problems (e.g. immunocompromised disease, major developmental or genetic abnormality)
  • 3. Gastrointestinal disorder
  • 4. Taking antibiotics four weeks prior to enrollment
  • 5. Using the same probiotic strains in this study two weeks prior to enrollment
  • 6. Taking antibiotics during the intervention

Investigators

Sponsor
Angel Children’s Hospital

Similar Trials